New liquid embolic shows promise for prostate troubles
NCT ID NCT07255508
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a liquid material called SQUIDPERI for a procedure that blocks blood flow to the prostate (prostatic artery embolization) in men with an enlarged prostate. The goal is to see if it works better than standard particles at easing urinary symptoms like frequent or weak urination. About 100 men will take part, and success is measured by symptom scores at 3 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATE HYPERTROPHY(BPH) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Arnaud de Villeneuve (Service Imagerie diagnostique et interventionnelle)
Montpellier, 34295, France
-
Hôpital Européen Georges Pompidou - AP-HP (Radiologie Interventionnelle vasculaire et oncologique)
Paris, 75015, France
-
Hôpital Timone (Radiologie adultes et neuroradiologie)
Marseille, 13385, France
-
Institut Cardiovasculaire de Strasbourg (ICS) - Clinique Rhena (Radiologie interventionnelle vasculaire et oncologique)
Strasbourg, 67000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One-shot hormone blocker may prevent repeat urinary blockages in men
- Steam power: can a quick vapor treatment ease prostate symptoms for years?
- New study pits two prostate surgeries Head-to-Head for better outcomes
- Natural supplement combo may match standard drug for prostate relief
- CoQ10 supplement tested for prostate relief
- Which prostate procedure spares your sex life? new study has answers